These include CTLA-4:CD80/CD86, PD1:PD-L1/PD-L2, GAL9:TIM3, TCR:LAG3, and HVEM:BTLA, all of which can contribute to the suppression of T cell effector function in the tumor microenvironment. The gene discussed is CD274; the disease is neoplasm.